Tom Kee likes BlackBerry but after the stock's meteoric start to 2014, he says it may be time for a breather.
Here's the problem with "buy and hold," says Stock Trader Daily's Thomas Kee: Do you have time to wait for it to pay off?
This has been a stellar year for the stock market but investors should be questioning this rally, said Stock Trader Daily's Thomas H. Kee, Jr.
You might say, Coke is it!
This week RNA firms appeared to have tough news, but Alnylam remains undeterred about the potential of its treatments.
It can take a while for the Street to recognize that a company has made big changes.
Art Cashin believes Wednesday's across-the-board rally could be the one to end the selloff in momentum stocks.
Get the best of CNBC in your inbox